2009
DOI: 10.1021/jo901345j
|View full text |Cite
|
Sign up to set email alerts
|

An Efficient and Diastereoselective Synthesis of PSI-6130: A Clinically Efficacious Inhibitor of HCV NS5B Polymerase

Abstract: R7128 is the prodrug of 2'-deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130), a potent and selective inhibitor of HCV NS5B polymerase. Currently, R7128 is in clinical trials for the treatment of HCV infection. To support clinical development efforts, we needed an efficient and scalable synthesis of PSI-6130. We describe an improved, diastereoselective synthetic route starting with protected d-glyceraldehyde. No chiral reagents or catalysts were used to produce the three new contiguous stereocenters. Introduction … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
68
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 84 publications
(70 citation statements)
references
References 22 publications
2
68
0
Order By: Relevance
“…HCV SPRINT-1 study Naı¨ve treatment-naïve [27,[32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][93][94][95][96][97][98] assessed the safety and efficacy of boceprevir, an oral inhibitor of HCV-NS3 protease, plus pegIFN alpha-2b and ribavirin (Table 4). SVR was significantly increased in the 28-and 48-week boceprevir arms compared to pegIFN alpha-2b and RBV control.…”
Section: Boceprevirmentioning
confidence: 99%
See 1 more Smart Citation
“…HCV SPRINT-1 study Naı¨ve treatment-naïve [27,[32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][93][94][95][96][97][98] assessed the safety and efficacy of boceprevir, an oral inhibitor of HCV-NS3 protease, plus pegIFN alpha-2b and ribavirin (Table 4). SVR was significantly increased in the 28-and 48-week boceprevir arms compared to pegIFN alpha-2b and RBV control.…”
Section: Boceprevirmentioning
confidence: 99%
“…The same as hepatitis B virus, human immunodeficiency virus, and herpes virus, HCV is thought to be a target of polymerase inhibitor. There are two classes: nucleoside inhibitors and non-nucleoside inhibitors (NNIs) [45]. These drugs reduce the efficiency of further RNA elongation.…”
Section: Hcv Ns5b Polymerase Inhibitorsmentioning
confidence: 99%
“…Modeling studies suggest that the 2`-C-methyl group of the incorporated nucleotide inhibitor might cause a steric conflict with the endogenous nucleotide substrate. 42 Therefore, Sofosbuvir and related 2`-C-methylated derivatives with a hydroxyl group or fluorine atom at the 2`-position act as potent chain terminators, such as PSI-6130, [43][44][45][46][47][48][49][50][51] Mercitabine, [52][53][54][55][56][57][58][59][60][61] …”
Section: Phosphoramidate Prodrugsmentioning
confidence: 99%
“…We had successfully developed a homochiral synthesis of the uridine nucleoside PSI-6206 starting with d-glyceraldehyde (Figure 8.9) [38]. Consequently, after the preparation of the phosphoramidate prodrug, we were able to separate the diastereomers of PSI-7851 using chromatographic methods which gave the two compounds PSI-7976 17 and PSI-7977 1 (Figure 8.8a) [31].…”
Section: The Single Diastereomer: Sofosbuvirmentioning
confidence: 99%